Zealand Pharma A/S (ZLDPF)
41.99
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Zealand Pharma Research and Development Expense (TTM) : 286.45M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 286.45M |
| March 31, 2026 | 276.67M |
| December 31, 2025 | 244.19M |
| September 30, 2025 | 197.89M |
| June 30, 2025 | 186.58M |
| March 31, 2025 | 146.60M |
| December 31, 2024 | 133.43M |
| September 30, 2024 | 124.54M |
| June 30, 2024 | 114.48M |
| March 31, 2024 | 106.68M |
| December 31, 2023 | 99.40M |
| September 30, 2023 | 94.19M |
| June 30, 2023 | 85.09M |
| March 31, 2023 | 84.05M |
| December 31, 2022 | 86.99M |
| September 30, 2022 | 89.31M |
| June 30, 2022 | 91.79M |
| March 31, 2022 | 94.29M |
| December 31, 2021 | 92.71M |
| September 30, 2021 | 95.89M |
| June 30, 2021 | 95.66M |
| March 31, 2021 | 90.23M |
| December 31, 2020 | 92.63M |
| September 30, 2020 | 91.68M |
| June 30, 2020 | 88.25M |
| Date | Value |
|---|---|
| March 31, 2020 | 89.88M |
| December 31, 2019 | 84.08M |
| September 30, 2019 | 78.37M |
| June 30, 2019 | 73.60M |
| March 31, 2019 | 72.42M |
| December 31, 2018 | 68.61M |
| September 30, 2018 | 63.92M |
| June 30, 2018 | 61.14M |
| March 31, 2018 | 55.47M |
| December 31, 2017 | 49.49M |
| September 30, 2017 | 44.27M |
| June 30, 2017 | 40.93M |
| March 31, 2017 | 38.99M |
| December 31, 2016 | 39.69M |
| September 30, 2016 | 36.77M |
| June 30, 2016 | 35.86M |
| March 31, 2016 | 33.54M |
| December 31, 2015 | 31.95M |
| September 30, 2015 | 33.48M |
| June 30, 2015 | 33.92M |
| March 31, 2015 | 32.95M |
| December 31, 2014 | 31.91M |
| September 30, 2014 | 29.15M |
| June 30, 2014 | 27.46M |
| March 31, 2014 | 26.44M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Genmab A/S | 1.781B |
| Ascendis Pharma A/S | 315.81M |
| Bavarian Nordic A/S | 102.03M |
| Evaxion AS | 10.27M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |